UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 439

Sortiert nach

HER2-low breast cancer could be associated with an increased risk of brain metastasis

International journal of clinical oncology, 2022-02, Vol.27 (2), p.332-339

2022

Link zum Volltext

Verfügbarkeit prüfen

Comments on “Association between immune checkpoint inhibitor‐induced myocarditis and concomitant use of thiazide diuretics”

International journal of cancer, 2024-02, Vol.154 (3), p.585-585

Guven, Deniz Can

2024

Link zum Volltext

Verfügbarkeit prüfen

Reassurance of patients with cancer on cancer care continuum: a vital strategy to prevent anxiety of COVID-19 collateral damage

Supportive care in cancer, 2021-07, Vol.29 (7), p.3423-3424

Guven, Deniz Can

2021

Link zum Volltext

Verfügbarkeit prüfen

Artificial intelligence method to predict overall survival of hepatocellular carcinoma

Hepatology Forum, 2021-05, Vol.2 (2), p.64-68

Simsek, Cem

2021

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant capecitabine in rectal cancer chemoradiotherapy: too early to ring the alarms

Internal medicine journal, 2021-08, Vol.51 (8), p.1365-1366

2021

Link zum Volltext

Verfügbarkeit prüfen

An external validation of the QCOVID3 risk prediction algorithm for risk of hospitalisation and death from COVID-19: An observational, prospective cohort study of 1.66m vaccinated adults in Wales, UK

PloS one, 2023-05, Vol.18 (5), p.e0285979-e0285979

2023

Link zum Volltext

Verfügbarkeit prüfen

Anti-spike protein to determine SARS-CoV-2 antibody levels: Is there a specific threshold conferring protection in immunocompromised patients?

PloS one, 2023-04, Vol.18 (4), p.e0281257-e0281257

2023

Link zum Volltext

Verfügbarkeit prüfen

The Association between the Pan-Immune-Inflammation Value and Cancer Prognosis: A Systematic Review and Meta-Analysis

Cancers, 2022-05, Vol.14 (11), p.2675

2022

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy in the First‐Line Treatment of Advanced Nasopharyngeal Carcinoma: A Systematic Review and Meta‐Analysis

The Laryngoscope, 2024-01, Vol.134 (1), p.7-17

2024

Link zum Volltext

Verfügbarkeit prüfen

The Efficacy and Safety of Neoadjuvant Immunotherapy in Patients with Non-Small Cell Lung Cancer

Cancers, 2023-12, Vol.16 (1), p.156

2023

Link zum Volltext

Verfügbarkeit prüfen

Gut microbiota and cancer immunotherapy: prognostic and therapeutic implications

Future oncology (London, England), 2020-03, Vol.16 (9), p.497-506

2020

Link zum Volltext

Verfügbarkeit prüfen

Perspectives, Knowledge, and Fears of Cancer Patients About COVID-19

Frontiers in oncology, 2020-08, Vol.10, p.1553-1553

2020

Link zum Volltext

Verfügbarkeit prüfen

The use of CDK 4/6 inhibitors in the adjuvant treatment of breast cancer: Timing matters

The breast journal, 2020-12, Vol.26 (12), p.2435-2436

2020

Link zum Volltext

Verfügbarkeit prüfen

The use of CDK 4/6 inhibitors in the adjuvant treatment of breast cancer: Timing matters

The breast journal, 2021-01, Vol.27 (1), p.104-104

2021

Link zum Volltext

Verfügbarkeit prüfen

The Predictive Value of Red Blood Cell Distribution Width for Survival Outcomes of Metastatic Renal Cell Carcinoma Patients Treated with Targeted Therapy

Nutrition and cancer, 2021-11, Vol.73 (10), p.1957-1963

2021

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity of two doses of inactive COVID‐19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy

International journal of cancer, 2023-02, Vol.152 (4), p.679-685

2023

Link zum Volltext

Verfügbarkeit prüfen

Comparison between vision transformers and convolutional neural networks to predict non-small lung cancer recurrence

Scientific reports, 2023-11, Vol.13 (1), p.20605-20605, Article 20605

2023

Link zum Volltext

Verfügbarkeit prüfen

A novel agnostic tumor: NTRKoma

Journal of oncology pharmacy practice, 2021-06, Vol.27 (4), p.802-803

2021

Link zum Volltext

Verfügbarkeit prüfen

Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy

Supportive care in cancer, 2021-09, Vol.29 (9), p.5417-5423

2021

Link zum Volltext

Verfügbarkeit prüfen

Targeting tumor microenvironment for cholangiocarcinoma: Opportunities for precision medicine

Translational oncology, 2022-11, Vol.25, p.101514-101514, Article 101514

2022

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of emergency departments visits in patients treated with immune checkpoint inhibitors

Supportive care in cancer, 2021-04, Vol.29 (4), p.2029-2035

2021

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of early unplanned readmissions and predisposing factors in an oncology clinic

Supportive care in cancer, 2021-07, Vol.29 (7), p.4159-4164

2021

Link zum Volltext

Verfügbarkeit prüfen

Chemoimmunotherapy for the salvage treatment of Ewing sarcoma: A case report

Journal of oncology pharmacy practice, 2021-07, Vol.27 (5), p.1281-1283

2021

Link zum Volltext

Verfügbarkeit prüfen

Learning From Failure: Negative Trials in Oncology

Journal of Immunotherapy and Precision Oncology, 2023-05, Vol.6 (2), p.59-60

2023

Link zum Volltext

Verfügbarkeit prüfen

Datopotamab deruxtecan: A novel antibody drug conjugate for triple-negative breast cancer

Heliyon, 2024-04, Vol.10 (7), p.e28385-e28385, Article e28385

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 439

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(376)
Mit Volltextzugriff
(379)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(17)

Menü

Weitere Dienste

Einstellungen

HER2-low breast cancer could be associated with an increased risk of brain metastasis

Comments on “Association between immune checkpoint inhibitor‐induced myocarditis and concomitant use of thiazide diuretics”

Reassurance of patients with cancer on cancer care continuum: a vital strategy to prevent anxiety of COVID-19 collateral damage

Artificial intelligence method to predict overall survival of hepatocellular carcinoma

Neoadjuvant capecitabine in rectal cancer chemoradiotherapy: too early to ring the alarms

An external validation of the QCOVID3 risk prediction algorithm for risk of hospitalisation and death from COVID-19: An observational, prospective cohort study of 1.66m vaccinated adults in Wales, UK

Anti-spike protein to determine SARS-CoV-2 antibody levels: Is there a specific threshold conferring protection in immunocompromised patients?

The Association between the Pan-Immune-Inflammation Value and Cancer Prognosis: A Systematic Review and Meta-Analysis

Immunotherapy in the First‐Line Treatment of Advanced Nasopharyngeal Carcinoma: A Systematic Review and Meta‐Analysis

The Efficacy and Safety of Neoadjuvant Immunotherapy in Patients with Non-Small Cell Lung Cancer

Gut microbiota and cancer immunotherapy: prognostic and therapeutic implications

Perspectives, Knowledge, and Fears of Cancer Patients About COVID-19

The use of CDK 4/6 inhibitors in the adjuvant treatment of breast cancer: Timing matters

The use of CDK 4/6 inhibitors in the adjuvant treatment of breast cancer: Timing matters

The Predictive Value of Red Blood Cell Distribution Width for Survival Outcomes of Metastatic Renal Cell Carcinoma Patients Treated with Targeted Therapy

Immunogenicity of two doses of inactive COVID‐19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy

Comparison between vision transformers and convolutional neural networks to predict non-small lung cancer recurrence

A novel agnostic tumor: NTRKoma

Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy

Targeting tumor microenvironment for cholangiocarcinoma: Opportunities for precision medicine

Evaluation of emergency departments visits in patients treated with immune checkpoint inhibitors

Evaluation of early unplanned readmissions and predisposing factors in an oncology clinic

Chemoimmunotherapy for the salvage treatment of Ewing sarcoma: A case report

Learning From Failure: Negative Trials in Oncology

Datopotamab deruxtecan: A novel antibody drug conjugate for triple-negative breast cancer

Suchergebnisse filtern